Vidya Sethuraman
India Post News Service
As COVID infections spread due to the high transmissibility of the Delta variant, four medical experts weigh in on key...
NEW DELHI: Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
"Another milestone...
NEW DELHI: The Sputnik V team on Wednesday confirmed that the temporary delay in delivery due to production scale-up will be fully resolved in...
NEW DELHI: The national capital reported 51 new COVID-19 cases, 95 recoveries and zero deaths, while the positivity rate stood at 0.09 per cent,...
NEW DELHI: The domestically developed Covaxin is effective against the Delta plus variant of Covid-19, claims Indian Council of Medical Research (ICMR) in its...
WASHINGTON: A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer...
NEW DELHI: In a relief to Delhiites from sultry weather conditions, several parts of the national capital received incessant rainfall on Tuesday morning. According to...
NEW DELHI: India has administered over 42.78 crore doses of COVID-19 vaccine in its ongoing inoculation drive so far, said the Ministry of Health and...
PR Newswire
GURGAON, India: As the levels of consciousness towards a healthy, cleaner, and greener lifestyle become increasingly prominent and brands face greater scrutiny, both...
NEW DELHI: Underfunding of the public healthcare system and the particularly disastrous Covid-19 second wave worsened health infrastructure and disproportionately affected health outcomes of...